Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
TempraMed Technologies Ltd. ( (TSE:VIVI) ) just unveiled an update.
TempraMed Technologies Ltd. has announced a strategic distribution partnership with Salomo Executive, a healthcare logistics company, to expand its presence in the Benelux region (Netherlands, Belgium, Luxembourg). This collaboration will enhance the accessibility of TempraMed’s temperature-controlled solutions for injectable medications across Western Europe, particularly benefiting the growing diabetes care market. The partnership aligns with TempraMed’s global growth strategy and aims to accelerate the introduction of its innovative products, supported by Salomo Executive’s extensive network in healthcare logistics and distribution.
More about TempraMed Technologies Ltd.
TempraMed Technologies Ltd. is a global leader in innovative, temperature-controlled medication storage solutions. The company develops patented, FDA-registered thermal insulation devices that operate without batteries or external power. With a product line that includes VIVI Cap and VIVI Epi, TempraMed is headquartered in Israel and has operations in North America, Europe, and Asia.
Average Trading Volume: 7,160
See more data about VIVI stock on TipRanks’ Stock Analysis page.